BTOG 2017 | Early clinical trials of immunotherapy treatment combinations
Juergen Wolf
Prof Jürgen Wolf, MD, University Hospital of Cologne, Cologne, Germany, talks about early clinical trials investigating combinations of immune checkpoint inhibitors with other immune-stimulatory molecules and other modulators of interactions in the immune system. Other areas of investigation examine combinations of immunotherapy with chemotherapy, or with radiotherapy. Prof Wolf highlights that predictive biomarkers need to be identified to guide combination treatment.
Recorded at the 2017 meeting of the British Thoracic Oncology Group (BTOG) in Dublin, Ireland.
Related videos
3:32
Accelerate, Coordinate, Evaluate (ACE) cancer care: the CRUK programme streamlining the care pathway
Sara Hiom
1:57
Lung cancer screening in the UK: CRUK, UK NSC, Public Health England & NHS England
Sara Hiom
3:11
The Recovery Package in lung cancer
Josie Roberts
3:36
Single-port VATS for NSCLC: outcomes related to smoking status
John Edwards
2:09
Psychological impact of lung cancer screening
Mamta Ruparel
et al.
